Presenter: James P. Boyd, DDS
Date: Friday, December 13, 2019
Time: 8:30am - 4:30pm
Sponsored by: NTI Therapeutic Protocol
Location: 1060 Main Street Suite 201, River Edge, NJ 07661
CE Credits: 7
AGD Code: 180
Subject: Occlusion Participation
*Breakfast & Lunch Included
This course focuses on the physiologic nature of nocturnal parafunction … how with infinite presentations from unnoticeable to thoroughly destructive, it can create signs and symptoms that can confound dentists and neurologists.
Attendees will learn:
- To identify how and why traditional occlusal splint therapy for bruxism can fail
- How to best manage parafunction
- The significant difference between occlusion and occluding
- The ins and outs of chairside anterior midpoint stop fabrication
- When to make a maxillary or mandibular device
- How to handle deep bites
- When a simultaneous occlusal adjustment is indicated
- When NOT to make a device
Attendees will learn:
- How to assist an neurologist in their management of a migraine sufferer
- To understand what the neurologist is trying to do
- How neurologists approach migraine prevention, namely trigeminal nociception
- That they can assist and provide profound and therapeutic treatment for migraine and headache
Attendees will have a better understanding of the nature and physiology of migraines, but more importantly, an understanding of the migraine sufferer!
Hands-On Splint Fabrication
Attendees will be fabricating NTI splints and also have an opportunity to self-fabricate the “SnoreHook, the FDA and Medicare approved device for snoring and obstructive sleep apnea.
About the Speaker
James P. Boyd, DDS
Having suffered with daily headaches and frequent migraines for 12 years, Dr. Boyd began experimenting with the basic diagnostic principles of occlusal therapy and expanding them into therapeutic protocols. His conclusion was that the primary cause of his condition (and the majority of his TMD patients) was not due to his occlusion, but to his occluding, namely the frequency, duration, and most importantly, intensity.
Eventually, Dr. Boyd developed the NTI (Nocioceptive Trigeminal Inhibition) Therapeutic Protocol. In 2001, after extensive clinical trials, the FDA cleared the NTI for “the prevention of medically diagnosed migraine pain”.
Dr. Boyd has since dedicated his career to enhancing the relationship between Neurology and Dentistry, via the third division of the trigeminal nerve. He is currently associated with The Headache Center, a neurology specialty clinic in San Diego, practicing with neurologist Andrew Blumenfeld, MD, where they have published and presented at several international scientific meetings.
*limited to 24 attendees